Rare Inherited Tumor Syndromes

Rare inherited tumor syndromes are genetic disorders characterized by a significantly increased risk of developing various tumor types, often at a young age. These syndromes are often caused by pathogenic mutations in tumor suppressor genes, DNA repair genes, or oncogenes, leading to impaired control of cell growth and tumor suppression. renal cell carcinoma, and pheochromocytoma; and Peutz-Jeghers syndrome (STK11/LKB1 mutations), marked by gastrointestinal polyps and pigmentation, with elevated risks for pancreatic, colorectal, and breast cancers.

Other rare syndromes include Birt-Hogg-Dubé syndrome (FLCN gene) leading to renal tumors and lung cysts, and ataxia-telangiectasia (ATM gene) presenting with neurological deficits and increased risk for leukemia and lymphoma. These conditions often follow autosomal dominant or recessive inheritance, meaning a single gene mutation from one or both parents, respectively, can confer risk. Management typically involves intensive tumor screening and genetic counseling to enable early detection and prevention strategies, improving outcomes for affected individuals and their families.